Coronavirus SARS-Cov-2 responsible for COVID-19 disease attached to human respiratory epithelial cells©M.Rosa-Calatraval/O.Terrier/A.Pizzorno/E.Errazuriz-cerda

Furthering scientific knowledge knows no frontiers. Therefore, Inserm would like to reaffirm that the countries of Africa are – more than ever – key scientific partners and that:

• Inserm has long been committed to numerous research projects with African countries concerning a variety of diseases, including Ebola, malaria, and HIV.

• Inserm is a signatory of the Global Code of Conduct for Research in Resource-Poor Settings.

• The Institute has made a commitment to respect the ethical principles applicable to all COVID-19 research according to World Health Organization (WHO) directives.

• Inserm is one of the 70 institutions having signed the coalition launched to accelerate research on the prevention and treatment of COVID-19 in low- and middle-income countries.

• Inserm, through the Reacting consortium, has an ethical charter for research conduct in emerging infectious disease epidemics.

These contents could be interesting :

Inserm and CNRS to Lead Large-Scale Program on Psychiatry Research

On July 18, 2022, France’s minister for Higher Education and Research Sylvie Retailleau announced an unprecedented psychiatry research effort in the form of 80 million euros allocated over five....

How Blood Stem Cells Detect Pathogens and Guide Immune Response

Correct immune system function depends on the continuous supply of white blood cells derived from stem cells that reside in the bone marrow.  These are known as blood stem....